为儿童医院的药剂师实施VancomycIn per药房教育培训 (VIPER) 计划
Laura Bio1, Shabnam Gaskari1, Hayden T Schwenk2
1Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, USA.
概括
在VIPER计划中,药剂师有效地接受了儿科万科米辛剂量的培训,包括AUC24和MIPD. 药剂师报告说,他们对这项教育举措的信心增加,满意度高.
科学领域:
- 儿科药理学 儿科药理学
- 临床药房教育 临床药房教育
- 治疗药物监测 治疗药物监测
背景情况:
- 儿童的万科米辛剂量存在挑战,新的AUC24和MIPD建议进一步复杂化了这一问题.
- 药剂师对于儿童患者安全有效使用万科米辛至关重要.
研究的目的:
- 描述VIPER计划的开发和实施.
- 支持一家儿童医院的药房主导的万科米辛治疗药物监测 (TDM) 服务.
主要方法:
- VIPER计划为药剂师提供了关于万科米辛原则的教育和能力评估.
- 药剂师在独立的TDM管理和年度维护培训之前完成了核心课程.
- 药剂师的看法通过年度调查来评估.
主要成果:
- 自2020年以来,已经培训了100多名药剂师.
- 89%的人认为VIPER对指导方针更新有效; 84%的人对万科米辛剂量更有信心.
- 能力评估显示高课程后的知识 (年均≥85%).
结论:
- 该VIPER计划成功支持了儿科万科米辛TDM服务.
- 药剂师报告高满意度,并认为该计划对教育和技能改进有效.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution
258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Drug Dosing: Infants and Children
257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238


